WITHROW EDWARD W III 5
5 · PARALLAX HEALTH SCIENCES, INC. · Filed Mar 17, 2022
Insider Transaction Report
Form 5
Withrow Edward W III
10% Owner
Transactions
- Other
PREFERRED STOCK (SERIES A)
2021-11-06+396,339→ 796,071 total(indirect: By Huntington Chase Financial Group) - Other
COMMON STOCK
2021-11-06+15,921,420→ 72,430,792 total(indirect: By LLC) - Other
PREFERRED STOCK (SERIES A)
2011-09-30$2.75/sh+36,339$99,932→ 399,732 total(indirect: By Huntington Chase Financial Group) - Other
PREFERRED STOCK (SERIES A)
2021-11-06−796,071→ 0 total(indirect: By Huntington Chase Financial Group) - Disposition to Issuer
STOCK OPTION
2021-03-31−3,000,000→ 1,000,000 total(indirect: By LLC)Exercise: $0.25Exp: 2022-12-31→ COMMON STOCK (3,000,000 underlying)
Footnotes (4)
- [F1]Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.
- [F2]Cumulative dividends in kind on Series A Preferred Stock.
- [F3]Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.
- [F4]Unvested stock options canceled upon resignation of Reporting Person.